Fidaxomicin
Jump to navigation
Jump to search
In infection disease, fidaxomicin is an macrocyclide antibiotic. It may be used to treat Pseudomembranous enterocolitis caused by clostridium difficile infection. ==History== Dificid brand of fidaxomicin was approved for Optimer Pharms by the Food and Drug Administration in the United States with a New Drug Application (NDA) in 2011.[1] ==Pharmacology== ===Administration=== ===Distribution=== ===Metabolism=== ===Excretion=== ===Toxicity=== Drug toxicity includes ==External links== The most up-to-date information about Fidaxomicin and other drugs can be found at the following sites.
- Fidaxomicin - FDA approved drug information (drug label) from DailyMed (U.S. National Library of Medicine).
- Fidaxomicin - Drug information for consumers from MedlinePlus (U.S. National Library of Medicine).
- Fidaxomicin - Detailed information from DrugBank.
==References==
- ↑ Anonymous. Drugs@FDA for FDA Application No. 201699. U S Food and Drug Administration